ROIV - Roivant Sciences Ltd.
29.52
1.670 5.657%
Share volume: 9,607,090
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$27.85
0.00
0.00%
Summary score
42%
Profitability
35%
Dept financing
23%
Liquidity
58%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-18.6%
Return on assets
-9.36%
Return on sales
-4873.95%
Return on invested capital
-86.56%
Total debt ratio
33.33%
Debt ratio change over timeo
-2%
Current Ratio
15.98%
Quick Ratio
8.61%
Cash Position Ratio
9.18%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-6.77%
Return on sales
-11928.08%
Return on invested capital
0%
Total debt ratio
15.3%
Debt ratio change over timeo
0%
Current Ratio
32.61%
Quick Ratio
0%
Cash Position Ratio
12.38%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-6.8%
Return on sales
-16966.13%
Return on invested capital
0%
Total debt ratio
18.3%
Debt ratio change over time
0%
Current Ratio
30.66%
Quick Ratio
0%
Cash Position Ratio
9.73%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-44.78%
Return on assets
-74.49%
Return on sales
4820.44%
Return on invested capital
97.75%
Total debt ratio
-200.02%
Debt ratio change over time
-2%
Current Ratio
-17.18%
Quick Ratio
-17.72%
Cash Position Ratio
-15.43%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ROIV | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -18.6% | 13.23% | 9.84% | 26.17% |
| Return on assets | -9.36% | 4.59% | 3.2% | 1.81% |
| Return on sales | -4873.95% | 30.04% | 25.15% | 24.65% |
| Return on invested capital | -86.56% | 8.51% | 10.28% | 4.83% |
| Profitability | 0% | 83% | 73% | 67% |
| Total debt ratio | 33.33% | 80.7% | 59.39% | 93.28% |
| Debt ratio change over time | -2% | -16.59% | -73.52% | 21.11% |
| Dept financing | 9% | 22% | 16% | 50% |
| Current Ratio | 32.61% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 12.38% | 0.14% | 0.46% | 0.15% |
| Liquididy | 75% | 5% | 6% | 4% |
| Short-term ratios | ROIV | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -6.77% | 5.82% | 4.08% | 0.78% |
| Return on sales | -11928.08% | 38.27% | 25.36% | 15.48% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 13% |
| Total debt ratio | 15.3% | 81.38% | 59.57% | 99.65% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 29% | 20% | 15% | 25% |
| Current Ratio | 32.61% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 12.38% | 0.14% | 0.46% | 0.15% |
| Liquididy | 50% | 26% | 22% | 15% |